Psychiatric diagnoses in 3275 suicidesa meta-analysis

Let’s start with a simple, hard question: when someone dies by suicide, how often was a mental disorder part of the story? For decades, the go-to way to answer that has been the psychological autopsy. It’s not crime scene investigation. It’s a careful, retrospective psychiatric reconstruction built from interviews with family and friends, medical charts, and other records. The method varies from study to study, but the goal is the same: piece together a postmortem clinical picture using standard diagnostic criteria. Arsenault-Lapierre, Kim, and Turecki pulled that scattered literature together. They searched the medical databases up to the end of 2002, tracked references backward through papers, and whittled an initial pile of one hundred fifty-two studies down to twenty-seven that met strict inclusion rules. Every retained paper used a psychological autopsy, diagnosed with a recognized system like the Diagnostic and Statistical Manual, the International Classification of Diseases, or the Research Diagnostic Criteria, and included people who died by suicide without preselecting a single disorder. All told, they synthesized findings from three thousand two hundred seventy-five suicides. The studies didn’t all look the same. Just over half were case-control designs, most were published after nineteen ninety, and their diagnostic lenses weren’t identical: about two-thirds used the Diagnostic and Statistical Manual, one in five used the International Classification of Diseases, and the rest used the Research Diagnostic Criteria. Some studies coded multiple diagnoses per person; others recorded only a principal diagnosis. To compare like with like, the team built two-by-two tables for sixteen diagnostic outcomes and used Mantel–Haenszel weighted odds ratios—the standard way to pool categorical data across studies—and ran chi-squared tests to probe regional differences. Here’s the headline. Across those twenty-seven studies, roughly eighty-seven percent of people who died by suicide had a diagnosable psychiatric disorder. The mean was eighty-seven point three percent, and about fourteen percent were reported without a diagnosis. In the subset of case-control designs, the contrast was stark: the mean percentage of controls with a disorder was about thirty-five percent. Put another way, the pooled odds of having any psychiatric diagnosis were more than ten times higher in those who died by suicide than in controls; the odds ratio for "any disorder" landed at ten point five, with a tight confidence interval. What kinds of diagnoses are we talking about? The most common broad category was affective disorders—depression and bipolar illness—present in about forty-three percent of cases. Substance-related disorders came next at roughly twenty-six percent. Personality disorders were recorded in about sixteen percent, and psychotic disorders, including schizophrenia, in about nine percent. That’s the averaged picture across diverse samples. Under the surface, many individuals carried more than one diagnosis. Some studies counted those comorbidities directly; others only logged the principal one. Zooming in on specific risks, schizophrenia and related psychotic disorders were clearly overrepresented when suicides were compared with controls. The odds ratio for schizophrenia was five point fifty-six. That finding is important, but fragile: very few controls had schizophrenia, which inflates uncertainty. At the other end of the spectrum, organic disorders and adjustment disorders showed little to no difference between suicides and controls; their odds ratios hovered close to one. Now, here’s where the pattern gets more textured. When the authors focused on the subset of studies that broke diagnoses out by sex, the overall rate of "any psychiatric disorder" didn’t differ between men and women who died by suicide. But the profiles did. Substance-related problems stood out in men. The odds that a male suicide had any substance disorder were more than three times those for a female suicide, and when you split that category, you see the same tilt: alcohol problems were about twice as likely in men, and other substance problems were similarly elevated. Two other categories followed the same male-skewed pattern. Personality disorders were about twice as common among male suicides as among female suicides. Childhood disorders were even more concentrated in males, with nearly a fivefold difference. Each of those comparisons came from the pooled Mantel–Haenszel estimates across the gender-reporting studies. Flip the lens, and you see the complementary pattern in women. Affective disorders—a category that includes depressive disorders—were relatively more common among female suicides. The way the authors report it is by showing lower odds for those disorders in men: for depressive disorders, the male-to-female odds ratio was zero point fifty-three; for the broader "any affective disorder," it was zero point sixty-six. Translate that out of statistic-speak, and it says depressive and mood disorders feature more often in the diagnostic histories of women who died by suicide than of men who did. Geography adds another layer. When Arsenault-Lapierre and colleagues grouped studies by world region and asked, "What’s the mix of diagnoses among suicide completers here versus there?", the proportions shifted. The fraction of suicides with at least one diagnosis was high everywhere, but it varied at the margins. European samples averaged about eighty-nine percent with a diagnosis; Australian samples were lower, around seventy-nine percent; North American and Asian samples sat in between. That overall difference wasn’t statistically strong, but the mix within that "diagnosed" bucket was. Take affective disorders. In Europe, nearly half of suicides were diagnosed with a mood disorder. In North America, about one-third were. In Asia, the proportion was slightly above half. Those differences weren’t random noise; the chi-squared tests the authors ran pointed to real variation. Substance diagnoses told a different geographic story. North America was higher—about forty percent—while Europe was lower at roughly nineteen percent, with Australia and Asia in the middle. And psychotic disorders swung sharply in Australia—about a quarter of suicides carried a psychosis diagnosis—compared with single-digit rates in Europe and North America. Personality disorders, interestingly, didn’t show the same kind of regional spread; the proportions were more tightly clustered and not statistically distinctive. If you’re hearing these numbers and thinking, "Okay, so most people who die by suicide had a mental disorder, but the exact mix depends on whether you’re looking at men or women, and where," that’s the right summary. But there’s another ingredient that matters a lot in clinical reality: comorbidity. Carrying more than one diagnosis isn’t just additive, it can be multiplicative for risk and complexity. The meta-analysis couldn’t fully quantify comorbidity across all included studies—too many primary reports left those data thin—but in the case-control studies that did measure it, the signals were strong. One comparison with matched community controls reported an odds ratio above three hundred for combined Axis I-Axis II comorbidity. That’s one sample, and the number is eye-popping, but the general theme was echoed elsewhere: when disorders stack, risk steepens. So, how solid is all of this? Solid enough to take seriously, but not so tidy that you can forget the caveats. The synthesis is built on retrospective informant interviews and record reviews. That’s the nature of psychological autopsy: you do your best to reconstruct, but you can’t examine the person directly. Studies differed in whether they captured secondary diagnoses, and four of them had to add secondary diagnoses to the principal ones after the fact to better reflect comorbidity. Diagnostic systems weren’t uniform, which matters when you’re comparing a Diagnostic and Statistical Manual-defined personality disorder to an International Classification of Diseases-defined one. And the samples aren’t perfectly comparable. Some case-control studies drew controls from psychiatric inpatients, which can blur contrasts, while others used community controls. Where two papers covered the same underlying population—think of the Rich and Foster studies—the meta-analysis handled them carefully to avoid double counting in any single analysis. The authors also flagged demographic quirks that could nudge patterns—American women, for example, were younger in some samples than women elsewhere, and Australian samples, for both men and women, skewed older. Age shapes diagnoses. So you have to read the sex and region differences with those context clues in mind. Still, the central line running through this body of evidence is remarkably straight. Psychopathology is closely tied to suicide. The pooled odds ratio of ten point five for "any diagnosis" isn’t subtle. And the internal contours—more substance and personality diagnoses among men, more affective diagnoses among women, higher substance proportions in North America, higher psychosis proportions in Australia—aren’t random scatter. They map onto patterns clinicians and public health workers see on the ground. What should you do with that? If you’re thinking in terms of assessment and prevention, it argues for sharpening the lens rather than blurring it. Yes, screen broadly for mental disorders in people at risk of suicide because the base rate in completers is high. But expect the diagnostic profile to differ by sex and by setting. In a North American clinic, you’re more likely to encounter substance problems in men who later die by suicide; in some European or Asian contexts, mood disorders may be more front and center among women. If you’re working with youth, be mindful that childhood-onset disorders, including those diagnosed in adolescence, show up more often in male suicides. None of that says, "Ignore the other categories." It says, "Tilt your attention where the data tell you the odds are steeper." There’s a temptation to leap from meta-analysis to mechanism—to ask why these differences exist and how biology, culture, access to care, and diagnostic habits interact to produce them. Those are worthy questions, but they’re mostly beyond the reach of the psychological autopsy method. This synthesis doesn’t resolve causality. It quantifies association, carefully and across a wide span of studies, and it shows that the association is strong and structured. That’s the payoff here. Across twenty-seven psychological autopsy studies totaling three thousand two hundred seventy-five suicides, about eighty-seven percent had a diagnosable psychiatric disorder, and the odds of any diagnosis were over ten times higher than in controls. Mood disorders were the single largest category. Substance disorders were second. Men showed more substance, personality, and childhood diagnoses; women showed more mood and depressive diagnoses. The regional mix of diagnoses varied in ways that make sense against local clinical backdrops. Comorbidity, when measured, mattered a lot. And the whole picture comes with the caveats of retrospective diagnosis and methodological heterogeneity. If you hold those pieces together, the story is both sobering and useful. Sobering, because psychiatric illness is the rule rather than the exception in people who die by suicide. Useful, because the pattern inside that rule can guide more nuanced, context-aware prevention—without pretending the data say more than they do.